This invention belongs to the field of
biosynthesis, specifically relating to a variant of
lysine pyrophosphate diol synthase and the constructed engineered
yeast strain for
perillaldehyde synthesis. To address the generally low yield of
perillaldehyde biosynthesis in existing technologies, this invention mutates and optimizes the
lysine pyrophosphate diol synthase to obtain an SsLPPs
mutant containing the G379M
mutation, which is then used for
perillaldehyde synthesis. Simultaneously, to address the genetic
instability issues associated with free
plasmid expression in some
Saccharomyces cerevisiae strains, this invention constructs a perillaldehyde synthesis pathway within the
yeast genome. Furthermore, by enhancing the acetyl-CoA synthesis pathway, the MVA pathway, and the perillaldehyde synthesis pathway, and by knocking out some transcriptional repressors, the substrate strain synthesizing perillaldehyde is modified, resulting in a significantly increased yield compared to existing technologies.